ONECUT3 and malignant colon neoplasm: The results demonstrated a significant decrease in the ECAR, an indicator of glycolysis, following ONECUT3 knockdown (Fig. 2D) and a substantial increase after ONECUT3 overexpression in colon cancer cells (Fig. 2F).